Biotech Startup
NanoBio In RSV Vaccine Research Effort With Merck
Nanobio Corp. Thursday announced a preclinical collaboration with a subsidiary of Merck & Co. Inc. focused on the development of a vaccine for Respiratory Syncytial Virus (RSV).
Listen Live!
Latest Galleries
-
Spring Storm Whips Through...
Ticket Chicks Car Wash 6.16.13
Detroit Tigers @ Minnesota...
Detroit Tigers @ Minnesota...
-
Detroit Tigers @ Minnesota...
Detroit Tigers @ Kansas City...
Flash Grenade Demonstration
Detroit Tigers @ Kansas City...
-
Orion Music Festival - Day Two
Detroit Tigers Vs. Cleveland...
Detroit Tigers Vs. Cleveland...
Metallica Performs As...
-
Detroit Tigers Vs. Cleveland...
Demolition Of Historic Globe...
Detroit Tigers Vs. Tampa Bay...
Whole Foods Detroit Grand...
CBS Detroit Blogs
- The Reunion Project – The Final Countdown (6/7) June 7, 2013
- A Guest’s Guide To Wedding Attire May 23, 2013
- ‘Bridging Michigan’s Workforce Divide’: Talent Matters May 23, 2013
- Career Moves: New Rules For The Job Search May 22, 2013
